Pharmaceutical Analysis

Latest News


The Column

The development and commercialisation of new medical drugs is a complex and costly process, but increasing pressure is being placed on drug companies to accelerate the timeline from discovery of new drugs, through to clinical trials and then to their release onto the market. The pharmaceutical industry continues to demand ever more advanced products aimed at improving health and the quality of modern-day life.

The Column

Janet Kelsey of The Column spoke to Frédéric Cheviron, Sales & Marketing Manager for Chiral Technologies Europe, about the technology they use in drug development and how companies can improve their method development.

A Matter of MALS

The Column

Janet Kelsey of The Column spoke to Geofrey K. Wyatt of Wyatt Technology about MALS technology and how standards set by the European Pharmacopoeia dictate the type of instrumentation used for characterizing hydroxyethyl starch for pharmaceutical use. The advantages of using MALS instrumentation are also explained.

13tree-735182-1408615832242.jpg

Budding potential

The Column

Poplar buds could hold untapped potential as an ingredient in anti-ageing skin creams, a study has found.